Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-01 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 353,381
2024-04-17 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +6,853 $2.14 $15K 8,144
2024-04-17 Dake Benjamin T SEE REMARKS Sale 10b5-1 −6,447 $22.32 $144K 1,697
2024-04-17 Dake Benjamin T SEE REMARKS Sale 10b5-1 −338 $23.17 $8K 1,359
2024-04-17 Dake Benjamin T SEE REMARKS Sale 10b5-1 −68 $23.97 $2K 1,291
2024-04-17 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −6,853 95,936
2024-04-17 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +4,000 $1.74 $7K 7,251
2024-04-17 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −3,689 $22.30 $82K 3,562
2024-04-17 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −311 $23.33 $7K 3,251
2024-04-17 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −503 2,511
2024-04-17 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −3,497 539
2024-04-16 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +10,000 $2.14 $21K 10,000
2024-04-16 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −4,491 $24.40 $110K 5,509
2024-04-16 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −5,509 $24.94 $137K 0
2024-04-16 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 363,381
2024-04-10 Eldridge George A SEE REMARKS Option exercise 10b5-1 +7,500 $2.14 $16K 9,460
2024-04-10 Eldridge George A SEE REMARKS Sale 10b5-1 −6,729 $26.77 $180K 2,731
2024-04-10 Eldridge George A SEE REMARKS Sale 10b5-1 −771 $27.56 $21K 1,960
2024-04-10 Eldridge George A SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −7,500 43,763
2024-04-09 GRAYZEL DAVID S. Director Sale −11,882 $28.15 $334K 14,502

Page 4 of 16 · 315 trades